Genomcore at MWC2026: Leading the Convergence of Precision Health, Elite Sports, and Data Governance
The 2026 edition of the Mobile World Congress (MWC) and 4YFN has solidified Genomcore BIMS as the technological gold standard for the secure management of multimodal biomedical data.
Following an intense week of activity in Barcelona, we look back on an edition that has marked a turning point for our platform. The industry's message is clear: robust healthcare data security and governance have moved from being an option to the sector's number one priority.
Multimodal Data: From the Lab to the Pitch
One of the major highlights of this edition was the participation of Miquel A. Bru, Co-founder & CBDO of Genomcore, on Radio Televisión Española (RTVE)'s "5.0" programme. In his interview with Manu Martínez, Miquel broke down the challenge of making sense of the growing data fragmentation in high-performance sports.
This integration capability is precisely the core of our technology, enabling medical teams to understand with precision how athletes adapt, fatigue, and recover.
Award-Winning Innovation and Stage Leadership
Genomcore's presence at MWC2026 went beyond data analysis; we were also protagonists on the main stages through our two technological pillars:
-
DIPCAN Project and PRECISEU IMPACT Recognition: On the AstraZeneca stage, Miquel A. Bru presented the evolution of the DIPCAN project — a benchmark in how genomics and AI are transforming clinical diagnostics today. In this context, Genomcore was honored at the PRECISEU IMPACT Awards for our essential technological contribution to this initiative.
-
Elite Health and Performance: Dr. Laura Isus, Co-founder & CSO of Made of Genes — Genomcore's spin-off specialized in personalized health — successfully led a high-level panel at the Sports Tomorrow Congress (STC) by Barça Innovation Hub. Alongside representatives from FC Barcelona, Paris Saint-Germain, and Liverpool FC, the discussion focused on the unbreakable link between precision health and top-tier sporting performance.
Innovation Ecosystems and the Power of Partnerships
Our success in this edition was driven by the support of key institutions such as Barcelona & Madrid Health Hub, Biocat, and the BioRegion of Catalonia. Their continuous backing turned our space into a strategic hub for networking. It has been a privilege to host delegations and professionals from leading entities such as Cuatrecasas, Deloitte, Roche, Angelini Pharma, Gebro Pharma, and Hospital del Mar, among others. These visits underscore the growing interest from the legal, consulting, and pharmaceutical sectors in robust data governance solutions like those offered by Genomcore.
We return from MWC with a clear confirmation: Genomcore BIMS is the necessary infrastructure for institutions to convert biomedical data into real, secure, and scalable clinical decisions.
We don't replace professionals; we help them. To achieve a personalized view of every player, we need tools that help us digest and integrate multimodal data: genomics, biomarkers, and lifestyle.
